Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Ventana, Astellas to Leverage Diagnostic Tests for Targeted Cancer Treatments

April 15, 2015 11:49 am | News | Comments

Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced it has entered into master collaboration agreement with Astellas Pharma Inc., an R&D-driven global pharmaceutical company headquartered in Japan, to develop novel automated tissue diagnostics in support of therapeutic compounds in development. Read more...

TOPICS:

IMS: U.S. Prescription Drug Spending Jumped 13% in 2014

April 15, 2015 11:40 am | by Linda A. Johnson, AP Business Writer | News | Comments

U.S. spending on prescription drugs soared last year, driven up primarily by costly breakthrough medicines, manufacturer price hikes and a surge from millions of people newly insured due to the Affordable Care Act. Read more..

How Molecule Protects Brain Cells in Parkinson’s Disease Model

April 15, 2015 11:35 am | by Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found how a widely known but little-studied enzyme protects brain cells in models of Parkinson’s disease. Read more...

TOPICS:
Advertisement

Adherence to Blood Thinner Best With Pharmacist Management, Researcher Says

April 15, 2015 11:28 am | by Tracie White, Stanford University | News | Comments

Researchers found that adherence to a new-generation anticoagulant, used to prevent stroke in heart disease patients, is best at sites with pharmacist-led management. Read more...

TOPICS:

Heart Metabolics, FDA Agree on Special Protocol Assessment for Perhexiline Single Phase 3 Trial

April 15, 2015 9:23 am | News | Comments

The FDA has agreed to a single, randomized, pivotal Phase 3 trial of 350 patients evaluating perhexiline for the treatment of moderate-to-severe HCM. Read more...

TOPICS:

FDA Accepts Teva's NDA for Bendamustine

April 15, 2015 9:16 am | News | Comments

This NDA requests FDA approval of the rapid infusion bendamustine HCl product for the treatment of patients with chronic lymphocytic leukemia. Read more...

TOPICS:

New Liver Cancer Treatment Approved in Europe

April 15, 2015 8:24 am | by University Medical Center Utrecht | News | Comments

A new treatment for liver cancer developed by the University Medical Center Utrecht has received the European CE mark for quality and safety. Read more...

TOPICS:

French Legislators OK Health Care Reform Targeting Anorexia

April 15, 2015 8:23 am | by The Associated Press | News | Comments

France's lower house of Parliament approved a draft law Tuesday tackling a range of public health problems, from smoking and drinking to obesity and anorexia. Read more...

TOPICS:
Advertisement

Sierra Leone Schools Re-Open After Ebola Closed for 9 Months

April 15, 2015 8:22 am | by Clarence Roy-Macaulay, Associated Press | News | Comments

Children in Sierra Leone returned to schools on Tuesday after staying at home for nine months because of the Ebola outbreak. Read more...

TOPICS:

Global Duchenne Muscular Dystrophy Treatment Market to See Spectacular Growth by 2019

April 15, 2015 8:22 am | by Nikhilesh Sanyal, Ph.D., GlobalData's Immunology Analyst | Articles | Comments

GlobalData’s latest report states that this growth will occur across six major markets. Read more...

TOPICS:

Scientific Breakthrough Unlocks Potential Novel Tendon Therapy

April 14, 2015 11:00 am | by University of Glasgow | News | Comments

Scientists are investigating a new therapy for the treatment of tendon injuries such as tennis elbow and Achilles tendinitis after gaining new insight into the condition. Read more..

TOPICS:

Recruiting the Entire Immune System to Attack Cancer

April 14, 2015 10:48 am | by MIT News | News | Comments

The human immune system is poised to spring into action at the first sign of a foreign invader, but it often fails to eliminate tumors that arise from the body’s own cells. Cancer biologists hope to harness that untapped power using an approach known as cancer immunotherapy. Read more..

TOPICS:

Actavis: No Apologies for Seeking Alzheimer's Drug Profits

April 14, 2015 10:38 am | by Larry Neumeister, Associated Press | News | Comments

A lawyer for the Irish manufacturer of an Alzheimer's drug urged a U.S. appeals court on Monday to let it replace a two-pill daily regimen with a single-dose version of the drug even if it cheats generic drugmakers of profits. Read more...

TOPICS:

Soligenix: FDA Clearance of Phase 3 Pediatric Crohn's Study

April 14, 2015 10:31 am | News | Comments

Soligenix, Inc. announced today that agreement has been reached with the US Food and Drug Administration (FDA) on the design of a pivotal, Phase 3 clinical trial evaluating its product, SGX203 (oral beclomethasone 17,21-dipropionate or BDP), in the treatment of pediatric Crohn's disease. Read more...

TOPICS:

Harvard's Hope for the Future of Healthcare

April 14, 2015 8:49 am | by Ryan Bushey, Associate Editor | Articles | Comments

Shortcomings in the fast-evolving digital health care arena are becoming obvious. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading